Showing results (31-40 of 367) with videos related to
Sort By:
Pageof 37
Journal of Cardiothoracic and Vascular Anesthesia|August 10, 2010
Comparative feasibility of myocardial velocity and strain measurements using 2 different methods with transesophageal echocardiography during cardiac surgeryGraeme MacLaren, Roman Kluger, Kim A Connelly, et al.Diabetologia|August 2, 2018
Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trialNaveed Sattar, David Fitchett, Stefan Hantel, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 26, 2017
Transcatheter edge-to-edge repair of anterior mitral flail through a dehisced annuloplasty ringEdwin C Ho, Naveed Ahmed, Kim A Connelly, et al.The Canadian Journal of Cardiology|April 28, 2015
Echocardiography vs. Cardiac Magnetic Resonance Imaging for the Diagnosis of Left Ventricular Thrombus: A Systematic ReviewIdan Roifman, Kim A Connelly, Graham A Wright, et al.Basic Research in Cardiology|December 22, 2016
Role of integrins in mediating cardiac fibroblast-cardiomyocyte cross talk: a dynamic relationship in cardiac biology and pathophysiologyRobert A Civitarese, Andras Kapus, Christopher A McCulloch, et al.Current Opinion in Cardiology|July 11, 2020
Stress cardiac MRI in stable coronary artery diseaseYin Ge, Djeven P Deva, Kim A Connelly, et al.Current Opinion in Cardiology|January 19, 2023
Chronic heart failure management in adult patients with congenital heart diseaseNitish K Dhingra, C David Mazer, Kim A Connelly, et al.Expert Review of Endocrinology & Metabolism|October 6, 2018
The non-glycemic effects of incretin therapies on cardiovascular outcomes, cognitive function and bone healthAmir Hanna, Kim A Connelly, Robert G Josse, et al.Circulation|January 23, 2003
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatideShaun G Goodman, David Fitchett, Paul W Armstrong, et al.The Canadian Journal of Cardiology|May 8, 2018
Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and ManagementPatrick Meagher, Mohamed Adam, Robert Civitarese, et al.Pageof 37